REFERENCES
- Gerson SL, Talbot GH, Hurwitz S, Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100:345–351.
- Massey E, Paulus U, Doree C, Stanworth S. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2009:CD005341. DOI:10.1002/14651858.CD005341.pub2.
- Seidel MG, Minkov M, Witt V, Granulocyte transfusions in children and young adults: does the dose matter? J Pediatr Hematol Oncol. 2009;31:166–172.
- Seidel MG, Peters C, Wacker A, Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant. 2008;42:679–684.
- Centers for Disease Control and Prevention. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol. 2013. http://www.cdc.gov/nhsn/PDFs/ Biovigilance/BV-HV-protocol-current.pdf. Accessed October 2013.
- Ozturkmen S, Altuntas F, Olcay L. Granulocyte transfusion therapy in paediatric patients with severe neutropenic infection. Transfus Apher Sci. 2013;48:381–385.
- Graham AS, Price TH, Brogan TV. Revisiting the use of granulocyte transfusions in pediatric oncology patients. J Pediatr Hematol Oncol. 2009; 31:161–165.
- Pham HP, Rogoza K, Stotler B, Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience. J Pediatr Hematol Oncol. 2010;34:e332–e336.
- Atay D, Ozturk G, Akcay A, Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions. J Pediatr Hematol Oncol. 2011;33:e220–e225.
- Stanworth SJ, Massey E, Hyde C, Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2005:CD005339. DOI:10.1002/14651858.CD005339.
- Ofran Y, Avivi I, Oliven A, Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang. 2007;93:363–369.
- Strauss RG. Role of granulocyte/neutrophil transfusions for haematology/oncology patients in the modern era. Br J Haematol. 2012;158(3):299–306.
- Cesaro S, Chinello P, De Silvestro G, Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer. 2003;11:101–106.
- Lee JJ, Chung IJ, Park MR, Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia. 2001;15:203–207.
- Peters C, Minkov M, Matthes-Martin S, Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol. 1999;106:689–696.